Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Arthritis Market

Companion Animal Arthritis Market Trends

Report ID: GMI10785
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Companion Animal Arthritis Market Trends

Veterinary clinics are adopting advanced imaging techniques, including MRI (magnetic resonance imaging) and CT (computed tomography) scans, to diagnose joint conditions in pets. These state-of-the-art tools provide veterinarians with detailed insights into joint structures, enabling them to devise more accurate treatment plans.

The rising prevalence of arthritis in companion animals drives the demand for advanced diagnostic tools and effective treatment options.
For example, veterinary research indicates that nearly 90% of cats and 20% of dogs exhibit some form of arthritis, with the likelihood increasing with age. A significant number of pets over seven years old show arthritis symptoms.
Additionally, the introduction of innovative therapeutic technologies and devices, such as laser treatments, customized rehabilitation programs, and activity monitors, is propelling the market's growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global companion animal arthritis market was valued at around USD 3.4 billion in 2023 and will register a 7.2% CAGR, driven largely by rising pet ownership, and higher incidence rate of arthritis among dogs and cats.

The medication segment was worth USD 1.5 billion in 2023, owing to its role in symptom management, in consort with advancements in veterinary medicine, such as better diagnostics, stronger medications, and comprehensive treatment protocols.

In 2023, North America captured a 45.6% share of the global companion animal arthritis market, with anticipated strong growth driven by increasing pet ownership, greater awareness of animal health, and advancements in veterinary care.

American Regent, Inc., Bayer AG (Bayer Animal Health), Boehringer Ingelheim International GmbH, CEVA Santé Animale, Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, Eltech K-Laser s.r.l., Medivet, Norbook Laboratories Ltd., Nutramax Laboratories Veterinary Sciences, Inc, Vetoquinol SA, Vibrac, and Zoetis, Inc.